147 related articles for article (PubMed ID: 15323391)
41. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
42. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
Hill RH; Shiels WE; Foster JA; Czyz CN; Stacey A; Everman KR; Cahill KV
Ophthalmic Plast Reconstr Surg; 2012; 28(2):119-25. PubMed ID: 22366666
[TBL] [Abstract][Full Text] [Related]
43. Current concepts in lymphatic malformation.
Lee BB; Kim YW; Seo JM; Hwang JH; Do YS; Kim DI; Byun HS; Lee SK; Huh SH; Hyun WS
Vasc Endovascular Surg; 2005; 39(1):67-81. PubMed ID: 15696250
[TBL] [Abstract][Full Text] [Related]
44. Cost-Effectiveness Analysis of Percutaneous Sclerotherapy for Venous Malformations.
Ono Y; Osuga K; Takura T; Nakamura M; Shibamoto K; Yamamoto A; Fujiwara H; Mimura H; Tomiyama N
J Vasc Interv Radiol; 2016 Jun; 27(6):831-7. PubMed ID: 26972615
[TBL] [Abstract][Full Text] [Related]
45. Current concepts in diagnosis and treatment of venous malformations.
Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
[TBL] [Abstract][Full Text] [Related]
46. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
[TBL] [Abstract][Full Text] [Related]
47. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
[TBL] [Abstract][Full Text] [Related]
48. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center.
Ali S; Weiss CR; Sinha A; Eng J; Mitchell SE
Phlebology; 2016 Oct; 31(9):603-9. PubMed ID: 27009607
[TBL] [Abstract][Full Text] [Related]
49. Staged endovascular and surgical treatment of slow-flow vulvar venous malformations.
Nassiri N; O TM; Rosen RJ; Moritz J; Waner M
Am J Obstet Gynecol; 2013 May; 208(5):366.e1-6. PubMed ID: 23395642
[TBL] [Abstract][Full Text] [Related]
50. Outcomes of sclerotherapy and embolization for arteriovenous and venous malformations.
Bowman J; Johnson J; McKusick M; Gloviczki P; Driscoll D
Semin Vasc Surg; 2013 Mar; 26(1):48-54. PubMed ID: 23932562
[TBL] [Abstract][Full Text] [Related]
51. Photoplethysmographic venous refilling times following ultrasound guided foam sclerotherapy for symptomatic superficial venous reflux: relationship with clinical outcomes.
Darvall KA; Sam RC; Bate GR; Adam DJ; Silverman SH; Bradbury AW
Eur J Vasc Endovasc Surg; 2010 Aug; 40(2):267-72. PubMed ID: 20362477
[TBL] [Abstract][Full Text] [Related]
52. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations.
Li L; Zeng XQ; Li YH
AJR Am J Roentgenol; 2010 May; 194(5):W439-44. PubMed ID: 20410391
[TBL] [Abstract][Full Text] [Related]
53. Sclerotherapy of peripheral low-flow vascular malformations: technical aspects and mid-term clinical outcome.
Giurazza F; Corvino F; Cangiano G; Amodio F; Cavaglià E; Silvestre M; De Magistris G; Tecame S; Niola R
Radiol Med; 2018 Jun; 123(6):474-480. PubMed ID: 29476439
[TBL] [Abstract][Full Text] [Related]
54. Five adult laryngeal venous malformation cases treated effectively with sclerotherapy.
Kamijo A; Hatsushika K; Kanemaru S; Moriyama M; Kase Y; Masuyama K
Laryngoscope; 2013 Nov; 123(11):2766-9. PubMed ID: 23553378
[TBL] [Abstract][Full Text] [Related]
55. Simultaneous intra-operative sclerotherapy and surgical resection of cervicofacial venous malformations.
MacArthur CJ; Nesbit G
Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():143-146. PubMed ID: 30634101
[TBL] [Abstract][Full Text] [Related]
56. Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience.
Grieb D; Meila D; Greling B; Jacobs C; Hechtner M; Schlunz-Hendann M; Brassel F
Acta Radiol; 2019 May; 60(5):593-601. PubMed ID: 30111191
[TBL] [Abstract][Full Text] [Related]
57. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin.
Liu Y; Liu D; Wang Y; Zhang W; Zhao F
J Oral Maxillofac Surg; 2009 Jan; 67(1):98-104. PubMed ID: 19070754
[TBL] [Abstract][Full Text] [Related]
58. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.
Choi YH; Han MH; O-Ki K; Cha SH; Chang KH
J Vasc Interv Radiol; 2002 May; 13(5):475-82. PubMed ID: 11997355
[TBL] [Abstract][Full Text] [Related]
59. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
Su L; Fan X; Zheng L; Zheng J
J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
[TBL] [Abstract][Full Text] [Related]
60. Patients with intralesional hemorrhage in venous malformations: diagnosis and embolosclerotherapy.
Chen H; Lin X; Jin Y; Li W; Ma G; Hu X
J Vasc Surg; 2009 Feb; 49(2):429-33; discussion 433-4. PubMed ID: 18945573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
